Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Optimization of stent implantation using a high pressure inflation protocol

Srikanth Vallurupalli MD1, Amit Bahia MD1, Ernesto Ruiz-Rodriguez MD1, Zubair Ahmed MD1,2, Abdul Hakeem MD1,2 andBarry F. Uretsky MD1,2,*

Background: High-pressure inflation is the universal standard for stent deployment but a specific protocol for its use is lacking. We developed a standardized “pressure optimization protocol” (POP) using time to inflation pressure stability as an endpoint for determining the required duration of stent inflation. Objectives: The primary study purpose was to determine the stent inflation time (IT) in a large patient cohort using the standardized inflation protocol, to correlate various patient and lesion characteristics with IT, and ascertain in an in vitro study the time for pressure accommodation within an inflation system.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of the boomerang wire vascular access management system versus manual compression alone during percutaneous diagnostic and interventional cardiovascular procedures: The boomerang™ wire vascular access management trial II

Nilesh J. Goswami MD1,†,*, Ronnie G. Smalling MD2, Shantanu Sinha MD3, Roger S. Gammon MD4 andVenkatesh G. Ramaiah MD5

Objectives: To evaluate the use of the Boomerang™ Wire as an adjunct to manual compression (MC) in patients requiring diagnostic (Dx) or interventional (Ix) percutaneous procedures.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention

Hiromasa Katoh MD, PhD*, Tsuyoshi Nozue MD, PhD andIchiro Michishita MD, PhD

Abstract: The patient was a 67-year-old man who had undergone coronary artery bypass graft surgery using a saphenous vein graft (SVG) 22 years before. Computed tomography angiogram revealed a large aneurysm of the SVG (38 × 42 mm in diameter; 80-mm long) and total occlusion of the left anterior descending artery (LAD). We first performed percutaneous coronary intervention for chronic total occlusion of the native LAD with bi-directional approach via the SVG. One month later, we performed the trans-catheter embolization of the SVG and occluded the SVG using multiple coils. This case demonstrates that trans-catheter embolization after recanalization of native coronary artery is an effective strategy to treat an SVG aneurysm. © 2015 Wiley Periodicals, Inc.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm

Barry F. Uretsky MD*, Jacob Mathew MD, Zubair Ahmed MD andAbdul Hakeem MD

Abstract: The patient with acute coronary syndrome, particularly with myocardial infarction, from an unprotected left main coronary stenosis represents one of the highest risk subgroups with mortality exceeding 25–50%. Once a patient develops cardiogenic shock, the risk of death during index hospitalization is exceedingly high. Percutaneous coronary intervention may improve short- and long-term outcome, particularly if performed prior to shock development. Should the patient survive index hospitalization, survival tends to be rather good. This review summarizes current knowledge and proposes a clinical algorithm for evaluation and treatment. © 2015 Wiley Periodicals, Inc.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Hybrid transatrial stent insertion for left atrial decompression in hypoplastic left heart syndrome with intact atrial septum

Objectives: To describe a novel strategy for the management of infants with hypoplastic left heart syndrome (HLHS) and intact atrial septum. Antenatally diagnosed infants are delivered in cardiac theatre and immediate left atrial decompression (LAD) using hybrid transatrial stent insertion (HTSI) via sternotomy is carried out.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization

Rebecca L. Noad MB, PhD, MRCP1,*, Nicola Johnston MD, MRCP1, Andrew McKinley MD, FRCS2, Mark Dougherty MD, FRCA3, O.C. Nzewi MD, FRCS, CTH4, Reuben Jeganathan MD, FRCS, CTH4, Ganesh Manoharan MD, MRCP1 andMark S. Spence MD, FRCP1

Introduction: There is considerable variability within the population of patients treated with transcatheter aortic valve implantation (TAVI), the procedural approach and time to discharge. In Belfast, from the commencement of our program, our approach has been to perform TAVI by the least invasive approach, where feasible, utilizing a percutaneous transfemoral route and local anesthetic. By analyzing our Belfast TAVI database we identified factors that predicted shorter admission times without impacting adversely on patient safety. Following this, we developed an early discharge pathway. The aim of this current study was to perform a prospective analysis of outcomes in our unit since implementation of this pathway assessing discharge time, mortality, serious adverse events, readmission, and resource implications for patients according to time to discharge.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Resource utilization for transfemoral transcatheter aortic valve replacement: An international comparison

Amar Krishnaswamy MD1, Azeem Latib MD2, Ali Malik MD1, Letizia Bertoldi MD2, Kanhaiya L. Poddar MD1, Alaide Chieffo MD2, Matteo Montorfano MD2, Lars G. Svensson MD, PhD3, Ottavio Alfieri MD2, Antonio Colombo MD4, E. Murat Tuzcu MD1 andSamir R. Kapadia MD1,*

Background: Transfemoral transcatheter aortic valve replacement (TF-TAVR) has enjoyed a rapid diffusion in the US and Europe, but the procedure is resource intensive.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Does the disparity in baseline characteristics of patients undergoing transcatheter aortic valve replacement with 23 mm vs. 26 mm valves impact clinical outcome?

Ricardo O. Escárcega MD, Marco A. Magalhaes MD, Nevin C. Baker DO, Michael J. Lipinski MD, PhD, Sa´ar Minha MD, Rebecca Torguson MPH, Fang Chen PhD, Lowell F. Satler MD, Augusto D. Pichard MD andRon Waksman MD*

Objectives: We sought to identify if baseline characteristic differences in patients who receive a 23 mm vs. 26 mm valve impact clinical outcomes.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling

Nazario Carrabba MD1,*, Guido Parodi MD1, Akiko Maehara MD2, Silvia Pradella MD3, Angela Migliorini MD1, Renato Valenti MD1, Vincenzo Comito MD1, Marco Marrani MD1, Luigi Rega MD3, Stefano Colagrande MD3, Gary S. Mintz MD2 andDavid Antoniucci MD1

Objectives: We sought to analyze whether rheolytic thrombectomy (RT) in comparison with manual thrombus aspiration (MTA) may reduce microvascular obstruction (MVO), infarct size (IS), and left ventricular (LV) remodeling in ST-elevation myocardial infarction (STEMI). Background: Conflicting results have been reported as to whether MTA reduces MVO and IS.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis

Yoshiki Matsuo MD, PhD, Takashi Kubo MD, PhD*, Hiroshi Aoki MD, Keisuke Satogami MD, Yasushi Ino MD, PhD, Hironori Kitabata MD, PhD, Akira Taruya MD, Tsuyoshi Nishiguchi MD, Ikuko Teraguchi MD, Kunihiro Shimamura MD, Yasutsugu Shiono MD, Makoto Orii MD, Takashi Yamano MD, Takashi Tanimoto MD, PhD, Tomoyuki Yamaguchi MD, Kumiko Hirata MD, PhD, Atsushi Tanaka MD, PhD andTakashi Akasaka MD, PhD

Objectives: The aim of this study was to determine the best threshold of postintervention minimum stent area (MSA) assessed by optical coherence tomography (OCT) to predict long-term in-stent restenosis (ISR) for 2.5 mm-diameter everolimus-eluting stents (EES).

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Coronary aneurysm and stent fracture following stenting of a myocardial bridge

Hao Lu MD, Lei Ge MD andJunbo Ge MD

Abstract: Myocardial bridge is the most common congenital coronary anomaly. We represent an extremely rare case of stent fracture combination with coronary aneurysm following stenting of a myocardial bridge. This 60-years-old male patient underwent coronary angiography in the local hospital four years ago. Coronary angiography revealed a myocardial bridge in the distal left anterior descending coronary artery (LAD). A 3.0 mm × 29 mm sirolimus eluting stent was deployed in the distal LAD. Three years later, repeat coronary angiography showed a large coronary aneurysm in the mid segment of the stent. The patient subsequently underwent coronary artery bypass grafting with left internal mammary artery (LIMA) to the distal segment of the LAD. But six months later, another coronary angiography showed a stent fracture in mid portion of the stent associated with a large coronary aneurysm, and the LIMA graft was totally occluded. A possible mechanism of stent fracture was long-standing and cyclic mechanical stress on the stent by myocardium. These forces over a period of time may lead to metal fatigue and eventually fracture. Based on the observation of fracture and aneurysm in this study, we recommend that myocardial bridge should not be treated with intracoronary stenting. © 2015 Wiley Periodicals, Inc.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Resolution of inferior venous baffle leak and total venous occlusion using a bare stent and the gore® excluder ® aortic extension in transposition of the great arteries after mustard procedure

Michael M. Ross MD, MS*, Marcus S. Schamberger MD andMark H. Hoyer MD, FACC, FSCAI

Abstract: We present a patient with a history of Mustard repair for transposition of the great arteries. The patient presented with complete inferior venous baffle obstruction and a large baffle leak after several years of cyanosis. Complete relief of the obstruction and exclusion of the baffle leak were accomplished with the use of a combination of bare metal stenting and the Gore® Excluder® aortic extender. To our knowledge, this represents the first reported use of the Gore® Excluder® aortic extender in the setting of inferior venous baffle leak and associated total inferior vena cava obstruction. © 2015 Wiley Periodicals, Inc.

01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Ductal stenting using side-branch cell dilation for aortic coarctation in high-risk patients with hypoplastic left heart syndrome

Masataka Kitano MD1,*, Satoshi Yazaki MD1 andKoji Kagisaki MD2

Abstract: For high-risk neonates with hypoplastic left heart syndrome (HLHS) undergoing Norwood operation, the strategy of bilateral pulmonary artery banding and ductal stenting is risky in case of coarctation of the aorta (CoA), often resulting in death. Therefore, we devised a new method of ductal stenting with side-branch cell dilation, which could overcome the constriction of the ductal arch with CoA in two HLHS patients. This is the first report that presents this method and the results. © 2015 Wiley Periodicals, Inc.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.